These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

627 related articles for article (PubMed ID: 28527613)

  • 21. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
    Hanley GE; McAlpine JN; Pearce CL; Miller D
    Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
    Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
    Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salpingectomy and the Risk of Ovarian Cancer in Ontario.
    Giannakeas V; Murji A; Lipscombe LL; Narod SA; Kotsopoulos J
    JAMA Netw Open; 2023 Aug; 6(8):e2327198. PubMed ID: 37566421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ACOG Committee Opinion No. 774 Summary: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):842-843. PubMed ID: 30913193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy.
    Ayres C; Ratnayake G; McNally O; Quinn M
    Int J Gynecol Cancer; 2017 May; 27(4):703-707. PubMed ID: 28399030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk-reducing bilateral salpingo-oophorectomy in women with BRCA1 or BRCA2 mutations.
    Eleje GU; Eke AC; Ezebialu IU; Ikechebelu JI; Ugwu EO; Okonkwo OO
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD012464. PubMed ID: 30141832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Fallopian Tubes in the Development of Ovarian Cancer.
    Corzo C; Iniesta MD; Patrono MG; Lu KH; Ramirez PT
    J Minim Invasive Gynecol; 2017 Feb; 24(2):230-234. PubMed ID: 28007588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The post-reproductive Fallopian tube: better removed?
    Dietl J; Wischhusen J; Häusler SF
    Hum Reprod; 2011 Nov; 26(11):2918-24. PubMed ID: 21849300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Not Available].
    Salvador S; Scott S; Francis JA; Agrawal A; Giede C
    J Obstet Gynaecol Can; 2017 Jun; 39(6):494-508. PubMed ID: 28527614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Revisiting the pathogenesis of ovarian cancer: the central role of the fallopian tube.
    Dietl J
    Arch Gynecol Obstet; 2014 Feb; 289(2):241-6. PubMed ID: 24100801
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tips and Tricks for Performing Salpingectomy at the Time of Laparoscopic Hysterectomy.
    Stuparich MA; Lee TTM
    J Minim Invasive Gynecol; 2017 Feb; 24(2):205. PubMed ID: 27956107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
    Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
    Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early detection of high-grade tubal serous carcinoma in women at low risk for hereditary breast and ovarian cancer syndrome by systematic examination of fallopian tubes incidentally removed during benign surgery.
    Rabban JT; Garg K; Crawford B; Chen LM; Zaloudek CJ
    Am J Surg Pathol; 2014 Jun; 38(6):729-42. PubMed ID: 24820399
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Do deeper sections increase the frequency of detection of serous tubal intraepithelial carcinoma (STIC) in the "sectioning and extensively examining the FIMbriated end" (SEE-FIM) protocol?
    Mahe E; Tang S; Deb P; Sur M; Lytwyn A; Daya D
    Int J Gynecol Pathol; 2013 Jul; 32(4):353-7. PubMed ID: 23722507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.
    Obstet Gynecol; 2019 Apr; 133(4):e279-e284. PubMed ID: 30913199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opportunistic salpingectomy for ovarian cancer prevention.
    Hanley GE; McAlpine JN; Kwon JS; Mitchell G
    Gynecol Oncol Res Pract; 2015; 2():5. PubMed ID: 27231565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic catastrophe, the peritoneal cavity and ovarian cancer prevention.
    Yoon JY; Chapel DB; Goebel E; Qian X; Mito JK; Horowitz NS; Miron A; Soong TR; Xian W; Crum CP
    J Pathol; 2022 Jul; 257(3):255-261. PubMed ID: 35238033
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome of risk-reducing salpingo-oophorectomy in BRCA carriers and women of unknown mutation status.
    Manchanda R; Abdelraheim A; Johnson M; Rosenthal AN; Benjamin E; Brunell C; Burnell M; Side L; Gessler S; Saridogan E; Oram D; Jacobs I; Menon U
    BJOG; 2011 Jun; 118(7):814-24. PubMed ID: 21392246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salpingectomy for the Primary Prevention of Ovarian Cancer: A Systematic Review.
    Kahn RM; Gordhandas S; Godwin K; Stone RL; Worley MJ; Lu KH; Long Roche KC
    JAMA Surg; 2023 Nov; 158(11):1204-1211. PubMed ID: 37672283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of salpingectomy at the time of urogynecologic surgery.
    Bradley MS; Visco AG
    Curr Opin Obstet Gynecol; 2015 Oct; 27(5):385-9. PubMed ID: 26308195
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.